Intrinsic Value

Lineage Cell Therapeutics, Inc. (LCTX)


+0.02 (+1.72%)

Enterprise Value -8,483.48
Net Debt -52.94
Equity Value -8,430.54
Shares Outstanding 164.50
Equity Value Per Share -51.25

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt